首页> 外文OA文献 >The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment

【2h】

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment

机译：炎症，抗血管生成剂和免疫检查点抑制剂之间的相互作用：肾细胞癌症治疗的透视

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nicole Brighi; Alberto Farolfi; Vincenza Conteduca; Giorgia Gurioli; Stefania Gargiulo; Valentina Gallà; Giuseppe Schepisi; Cristian Lolli; Chiara Casadei; Ugo De Giorgi;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? [J] . Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2020,第期

机译：抗血管生成剂在抗免疫检查点抑制剂的年龄：它们在非癌基因上瘾的非小细胞肺癌中具有作用吗？
2. Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer [J] . Chih‐Hsi Scott Kuo, Chin‐Chou Wang, Yu‐Chen Huang, Thoracic cancer. . 2019,第5期

机译：单独用途化疗和免疫检查点抑制剂和免疫检查点抑制剂的组合比较治疗晚期和转移性非小细胞肺癌
3. New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies [J] . Progress in Artificial Intelligence . 2020,第2期

机译：新的第一线治疗方法的透明细胞肾细胞癌PD-1或PD-L1免疫检查点抑制剂的组合疗法
4. Useful Combination Therapy of Anti-angiogenic Agent with Chemotherapeutic Agents or RadionuclideTherapy for Cancer Treatment [C] . Sun-Ju Choi, So-Young Lee, Young-Don Hong Controlled Release Society Annual Meeting and Exposition . 2007

机译：抗血管生成剂与化学治疗剂或放射性核素的有效组合疗法可用于癌症治疗
5. Exploring the Effect of Chronic Inflammation on Response to Immune Checkpoint Inhibitors in Cancer [D] . El-Refai, Sherif M. 2018

机译：探索慢性炎症对癌症对免疫检查点抑制剂反应的影响
6. The Interplay between Inflammation Anti-Angiogenic Agents and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment [O] . Nicole Brighi, Alberto Farolfi, Vincenza Conteduca, 2019

机译：炎症抗血管生成剂和免疫检查点抑制剂之间的相互作用：肾细胞癌治疗的观点。
7. Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer [O] . Likui Fang, Wuchen Zhao, Bo Ye, 2021

机译：非小细胞肺癌脑转移中免疫检查点抑制剂和抗血管生成剂的组合

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment

著录项

引文网络

相似文献

相关主题

期刊订阅